Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
9 9 Search
2025
Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis
Current Drug Targets
2025
Cytomegalovirus Reactivation in Diffuse Large B-cell Lymphoma Treated with Polatuzumab Vedotin:
The Kitakanto Medical Journal
2023
Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis
Autoimmunity Reviews
2021
Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology
Journal of Cutaneous Pathology
2021
Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients
Annals of Hematology
2020
Rituximab in people living with HIV affected by immune-mediated renal diseases: a case-series
International Journal of STD & AIDS
2019
Lymphoid Interstitial Pneumonia in Common Variable Immune Deficiency – Case Report With Disease Monitoring in Various Therapeutic Options: Pleiotropic Effects of Rituximab Regimens
Frontiers in Pharmacology
2017
T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy
Mediators of Inflammation
2017
The utility of monitoring peripheral blood lymphocyte subsets by flow cytometric analysis in patients with rheumatological diseases treated with rituximab
Autoimmunity Reviews